Methods of implantable cardioverter-defibrillator-pacemaker insertion to avoid interactions.
Experience with combined transvenous pacemaker and implantable cardioverter-defibrillator insertion in 21 patients is described. Special techniques are needed to avoid potentially lethal pacemaker-implantable cardioverter-defibrillator interaction. Separation between leads for the two devices should be maximized. The electrophysiologic criteria for successful device function can be met, even when some leads for both devices must be placed by a transvenous approach.
Spotnitz
H M
HM
Department of Surgery, Columbia-Presbyterian Medical Center, New York, New York 10032.
Ott
G Y
GY
Bigger
J T
JT
Steinberg
J S
JS
Livelli
F
F
D001145:Arrhythmias, Cardiac / Q000628:therapy*; D001281:Atrial Fibrillation / Q000628:therapy; D003131:Combined Modality Therapy; D004554:Electric Countershock / Q000295:instrumentation*; D004567:Electrodes, Implanted; D004868:Equipment Failure; D006801:Humans; D010138:Pacemaker, Artificial